Tanaka T - Search Results

1

Small cell carcinoma of the ovary: clinical and biological study.

Isonishi S, Nishii H, Saitou M, Yasuda M, Kiyokawa T, Fukunaga M, Ishikawa H, Tanaka T. Isonishi S, et al. Among authors: tanaka t. Int J Clin Oncol. 2008 Apr;13(2):161-5. doi: 10.1007/s10147-007-0698-2. Epub 2008 May 8. Int J Clin Oncol. 2008. PMID: 18463962

2

Primary chemotherapy-associated effect of second-line chemotherapy on survival of patients with advanced ovarian cancer.

Isonishi S, Hirama M, Saitou M, Yasuda M, Tanaka T. Isonishi S, et al. Among authors: tanaka t. Int J Clin Oncol. 2006 Jun;11(3):236-42. doi: 10.1007/s10147-006-0561-x. Int J Clin Oncol. 2006. PMID: 16850131

3

Differential regulation of the cytotoxicity activity of paclitaxel by orobol and platelet derived growth factor in human ovarian carcinoma cells.

Isonishi S, Saitou M, Saitou M, Yasuda M, Tanaka T. Isonishi S, et al. Among authors: tanaka t. Oncol Rep. 2007 Jul;18(1):195-201. Oncol Rep. 2007. PMID: 17549368

4

Alpha-fetoprotein (AFP)-producing ovarian tumor in an elderly woman.

Isonishi S, Ogura A, Kiyokawa T, Suzuki M, Kunito S, Hirama M, Tachibana T, Ochiai K, Tanaka T. Isonishi S, et al. Among authors: tanaka t. Int J Clin Oncol. 2009 Feb;14(1):70-3. doi: 10.1007/s10147-008-0800-4. Epub 2009 Feb 20. Int J Clin Oncol. 2009. PMID: 19225928

5

Drug sensitivity-related benefit of systematic lymphadenectomy during cytoreductive surgery in optimally debulked stages IIIc and IV ovarian cancer.

Isonishi S, Niimi S, Sasaki H, Ochiai K, Yasuda M, Tanaka T. Isonishi S, et al. Among authors: tanaka t. Gynecol Oncol. 2004 Jun;93(3):647-52. doi: 10.1016/j.ygyno.2004.03.006. Gynecol Oncol. 2004. PMID: 15196859

6

Enhancement of sensitivity to cisplatin by orobol is associated with increased mitochondrial cytochrome c release in human ovarian carcinoma cells.

Isonishi S, Saitou M, Yasuda M, Ochiai K, Tanaka T. Isonishi S, et al. Among authors: tanaka t. Gynecol Oncol. 2003 Aug;90(2):413-20. doi: 10.1016/s0090-8258(03)00316-0. Gynecol Oncol. 2003. PMID: 12893210

7

Recurrent small cell carcinoma of the ovary treated with docetaxel: A case report.

Niimi S, Kiyokawa T, Takakura S, Ochiai K, Tanaka T. Niimi S, et al. Among authors: tanaka t. Int J Gynecol Cancer. 2006 Sep-Oct;16(5):1944-6. doi: 10.1111/j.1525-1438.2006.00707.x. Int J Gynecol Cancer. 2006. PMID: 17009997

8

Establishment and characterization of a human ovarian small cell carcinoma, hypercalcemic type, cell line (OS-1) secreting PTH, PthrP and ACTH--special reference to the susceptibility of anti-cancer drugs.

Ohi S, Niimi S, Okada N, Yamada K, Tachibana T, Hashimoto H, Nakajima M, Yasuda M, Tanaka T, Sato K, Ishikawa H. Ohi S, et al. Among authors: tanaka t. Hum Cell. 2004 Dec;17(4):203-9. doi: 10.1111/j.1749-0774.2004.tb00044.x. Hum Cell. 2004. PMID: 16035505

9

Short-term serum deprivation confers sensitivity to taxanes in platinum-resistant human ovarian cancer cells.

Isonishi S, Saito M, Saito M, Tanaka T. Isonishi S, et al. Among authors: tanaka t. Int J Gynecol Cancer. 2011 Dec;21(9):1547-54. doi: 10.1097/IGC.0b013e318231b994. Int J Gynecol Cancer. 2011. PMID: 22080896

10

Preoperative diagnosis of malignant transformation arising from mature cystic teratoma of the ovary.

Mori Y, Nishii H, Takabe K, Shinozaki H, Matsumoto N, Suzuki K, Tanabe H, Watanabe A, Ochiai K, Tanaka T. Mori Y, et al. Among authors: tanaka t. Gynecol Oncol. 2003 Aug;90(2):338-41. doi: 10.1016/s0090-8258(03)00259-2. Gynecol Oncol. 2003. PMID: 12893196

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,388 results

Search Page

Filters